Pycnogenol (Skin).
May improve skin elasticity and hydration. Acts as a potent antioxidant for your skin. It helps protect against damage and some studies suggest it can improve skin elasticity and hydration.
Reviewed March 2026
- Category
- Antioxidant
- Also filed under
- Skin Health
What Pycnogenol (Skin) is, and what it does.
- Does it work
- Suits people already using sunscreen and a moisturiser who want an oral addition aimed at skin firmness and hydration. Anyone on blood thinners should check with their doctor first.
- How much to take
- 50-100mg per day. Stick with that range. More isn't proven to be better.
- Time to feel it
- Skin hydration and elasticity readings in trials shift over roughly six to twelve weeks of daily use. Microcirculation measures move earlier, within a few weeks.
- The first dose
- Absolutely nothing. This needs weeks to build up and exert its effects.
- With regular use
- After 1-3 months, you might see some subtle improvements in skin hydration and firmness. The benefits are gradual and not dramatic.
- How well tolerated
- Generally well tolerated. The main watch-out is for people on blood thinners. Otherwise, very few side effects are reported at standard doses.
- How it feels
- Like nothing. It works in the background. The 'feeling' is what you might see in the mirror after a couple of months.
- The overlooked benefit
- Much of the activity comes from what your gut bacteria make of it, so the metabolite that reaches your blood varies from person to person with their microbiome.
50 to 100mg a day is where Pycnogenol (Skin) works.
Source: Gulati 2014 US Pharm review; Belcaro et al. multiple RCTs on venous health.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
While some studies show positive effects on skin health, more research is needed to confirm these benefits definitively. The existing evidence is promising but not conclusive.
- Skin elasticity and hydrationRandomised trial
- Skin microcirculationRandomised trial
- Endothelial functionMeta-analysis
- Antioxidant capacity markersRandomised trial
- Leg swelling on long flightsRandomised trial
Questions people ask about Pycnogenol (Skin).
- Is this the same as pine bark extract?
- Yes, Pycnogenol is a specific, trademarked brand of French maritime pine bark extract. Generic versions exist, but Pycnogenol is what's used in most studies.
- Will this get rid of my wrinkles?
- No. It might improve skin elasticity and hydration, which can make fine lines less noticeable. It's not a facelift in a pill.
- How long until I see results?
- Be patient. Most studies run for 4-12 weeks before measuring changes.
- Best time to take it?
- Anytime. With or without food is fine. Consistency is more important than timing.
- Any side effects?
- Rare at normal doses. Some people report mild dizziness or stomach upset, but it's uncommon.
- Can I get this from food?
- No. It's exclusively from the bark of the French maritime pine tree. You have to supplement.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Pine bark procyanidins donate electrons that return oxidised ascorbate to its active form, so the two spare each other in the aqueous phase. Ascorbate is separately the required cofactor for the prolyl and lysyl hydroxylases that cross-link new collagen in skin.
Alpha-tocopherol works in the lipid membrane and becomes a tocopheroxyl radical once it acts. Ascorbate and procyanidins at the membrane interface hand electrons back to it, so the membrane pool keeps regenerating.
Dihydrolipoate regenerates ascorbate and glutathione, which sit upstream of the tocopherol pool. Adding it to a procyanidin extract gives the same recycling chain two entry points.
Collagen peptides supply the glycine, proline and hydroxyproline that dermal fibroblasts build new fibrils from. Procyanidins bind collagen and elastin fibres and slow their enzymatic breakdown, so one adds substrate while the other reduces turnover.
Both extracts are dominated by oligomeric procyanidins built from the same catechin and epicatechin units. Stacking them adds dose of one compound class rather than a second mechanism, which matters when a formula counts them as separate actives.
Pine bark procyanidins reduce platelet aggregation, and long-chain omega-3s shift eicosanoid production toward less aggregatory species. The two effects add, which is worth flagging for anyone already on a blood-thinning regimen.
Ginkgolides antagonise platelet-activating factor while procyanidins reduce platelet aggregation by a separate route. The two effects on normal clotting stack.
Hyaluronic acid holds water in the dermal matrix, while pine bark procyanidins are described as acting on collagen and elastin turnover and on microcirculation in the skin. The two address different structural elements. Combination data specific to this pair is not in the candidate set.
Proline is hydroxylated to hydroxyproline by prolyl hydroxylase, an ascorbate-dependent step, and this residue is what stabilises the collagen triple helix. Supplying the substrate sits upstream of any effect on matrix quality. This is textbook collagen biochemistry, not an outcome claim for the pair.
Lysine residues are hydroxylated and then oxidised by lysyl oxidase to form the covalent crosslinks that give mature collagen its tensile strength. Without lysine the crosslinking step has no substrate. Established chemistry rather than a measured combination.
Every third residue in collagen is glycine, because only its single hydrogen side chain fits at the crowded centre of the triple helix. Collagen synthesis therefore draws heavily on glycine supply. A structural fact of the protein, not a claim about skin appearance.
Zinc is the catalytic metal in the matrix metalloproteinases that remodel dermal collagen and in numerous transcription factors involved in keratinocyte turnover. Procyanidins are described as modulating the activity of those same enzymes. Cofactor availability sits upstream of the remodelling process.
Orthosilicic acid has been described in connective tissue research as associated with collagen formation and matrix integrity. The mechanism is not fully worked out and the evidence is thinner than for the amino acid substrates. Pair it as a supporting nutrient, not a driver.
Niacinamide is a precursor to NAD, which keratinocytes draw on for energy metabolism and DNA repair enzymes, particularly after ultraviolet exposure. Procyanidins act on the oxidative and NF-kB side of the same exposure. The mechanisms are separate, so the effects are not redundant.
Astaxanthin works inside the lipid bilayer while procyanidins and their metabolites act largely in the aqueous phase and at membrane surfaces. Covering both compartments is the usual argument for combining them in skin formulations. Support is mechanistic rather than a combination trial.
Lycopene deposits in the skin and is consumed preferentially during ultraviolet exposure, which is why it is used in oral photoprotection formulations. Procyanidins act on a different arm of the same oxidative response. No combination data appears in the candidate set.
Ubiquinol regenerates the tocopheroxyl radical inside membranes and is itself part of the mitochondrial electron chain in skin cells. Procyanidins sit at the aqueous interface of that same network. The pairing is a redox network argument.
Glutathione is the main intracellular thiol buffer and keeps ascorbate reduced, which in turn regenerates other antioxidants. Pine bark procyanidins appear repeatedly alongside glutathione measures in the oxidative stress literature for this extract. What is reported is a marker of redox status, not a clinical outcome.
N-acetylcysteine supplies cysteine, the rate-limiting amino acid for glutathione synthesis. Raising glutathione supports the recycling chain that polyphenol antioxidants depend on. This is settled biochemistry, and it is upstream of any skin-level effect rather than being one.
MSM is used in skin formulations as a sulfur source and appears alongside collagen support ingredients. The mechanism attributed to it is less well characterised than the amino acid substrates. Keep the expectation modest.
A pilot study paired the pine bark extract with pomegranate extract and reported on pigmentation and skin lightness measures in skin of colour. Pomegranate ellagitannins are metabolised by gut bacteria to urolithins, a different metabolite class from procyanidin-derived valerolactones. A pilot design cannot separate the contribution of each component.
Both are polyphenols described against NF-kB dependent gene expression in skin cells after ultraviolet exposure. The overlap makes them plausibly reinforcing on the same pathway rather than covering different ground. Evidence is mechanistic and largely cell-based.
Quercetin and the procyanidin monomers are both flavonoids conjugated by the same phase II sulfotransferase and UGT enzymes after absorption. That shared handling can mean competition for conjugation capacity as well as additive antioxidant activity. The net direction has not been measured for this pair.
Salicin from willow bark is converted to salicylic acid, which inhibits platelet cyclooxygenase, and pine bark procyanidins have been described as reducing platelet aggregation. Two agents pushing the same direction compound the effect. Worth flagging for anyone on antiplatelet medication or approaching surgery.
Nattokinase acts on fibrin, and this extract has been described as affecting platelet aggregation. Stacking them adds two influences on how readily blood clots. This is a caution to surface, not a benefit pairing.
Citrulline is converted to arginine, the substrate for endothelial nitric oxide synthase, while procyanidins are described as increasing eNOS activity itself. Substrate plus enzyme activity is a coherent pairing for microcirculation, which is the mechanism cited in the skin microperfusion work. The pair has not been trialled together.
Ceramides are the structural lipids of the stratum corneum barrier, addressing water loss at the surface, whereas procyanidins act in the dermal compartment on matrix and microcirculation. Different layers, different targets. No combination data here.
Talk to a doctor before taking Pycnogenol (Skin) if any of these apply to you: Pregnancy, Breastfeeding, Blood thinning medications. These are flags to check first, not effects Pycnogenol (Skin) is known to cause.
Not medical advice. Show the label to your pharmacist.What Pycnogenol (Skin) actually does.
The extract is a mixture of oligomeric proanthocyanidins built from catechin and epicatechin units, together with smaller phenolic acids such as ferulic and caffeic acid.
Absorbed phenolics are rapidly conjugated in the enterocyte and liver by UDP-glucuronosyltransferases, sulfotransferases and catechol-O-methyltransferase, so circulating forms are mostly glucuronides and sulfates rather than the parent compound.
Polyphenols of this class donate hydrogen from their catechol hydroxyl groups to reduce radicals, and the resulting phenoxyl radical is stabilised by delocalisation across the aromatic ring.
Procyanidins chelate transition metals including iron and copper, which removes the catalyst for Fenton chemistry and is a separate route from direct radical scavenging.
Where Pycnogenol (Skin) comes from.
It is made from the bark of a French maritime pine, taken from trees already cut for timber. The bark is washed, extracted with water and alcohol, boiled down, checked for how much of the active polyphenol it contains, and dried into a powder.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Bark of Pinus pinaster, taken from trees grown for timber in the Landes forest of southwest France, so the bark is a by-product of an existing harvest rather than a separate felling.
Washed and milled bark is extracted with water and ethanol, which pulls out the procyanidin oligomers along with phenolic acids.
The extract is concentrated under reduced pressure and the ethanol is stripped, leaving an aqueous polyphenol concentrate.
The concentrate is assayed for procyanidin content and adjusted to the declared specification before drying.
Dried to a free-flowing powder for capsules, tablets, dispersible sachets or cosmetic solutions.
The forms it comes in.
The essence, in one line each.
- Outdoor workers taking oral Pycnogenol for twelve weeks showed lighter skin pigmentation and better skin hydration and barrier measures than placebo.Randomised trial. Zhao et al., 2021 (Skin pharmacology and physiology). PMID 33789311 ↗
- Twelve weeks of Pycnogenol in older women raised skin elasticity and hydration, alongside increased gene expression for collagen type I and hyaluronic acid synthase.Randomised trial. Marini et al., 2012 (Skin pharmacology and physiology). PMID 22270036 ↗
- Supplementation with the pine bark extract plus a standardised Centella preparation was reported to improve skin elasticity and microperfusion measures in the supplemented group.Open-label trial. Cotellese et al., 2024 (Minerva Surgery). PMID 39259143 ↗
- A pilot study of the pine bark extract with pomegranate extract reported changes in pigmentation and skin lightness measures; a pilot design cannot attribute the change to either component alone.Open-label trial. Arunachalam et al., 2026 (Journal of Cosmetic Dermatology). PMID 41841561 ↗
- The extract was reported to reduce solar ultraviolet-induced erythema in human skin and to affect NF-kB-dependent gene expression in keratinocytes, a mechanistic readout rather than a clinical outcome.In vitro and human skin study. Saliou et al., 2001 (Free Radical Biology and Medicine). PMID 11163532 ↗
- A double-blind placebo-controlled trial of a multi-ingredient supplement reported improvements in skin smoothness and elasticity; the design cannot attribute the result to any single component of the formulation.Randomised trial. Segger et al., 2004 (Journal of Dermatological Treatment). PMID 15764035 ↗
- A review summarises the antioxidant, anti-inflammatory and immunomodulatory activities reported for the extract across preclinical and clinical work, and calls the human evidence base uneven.Narrative review. Kayesh et al., 2026 (Frontiers in Pharmacology). PMID 41878337 ↗
- The extract was reported to support nerve regeneration and functional recovery measures after a sciatic nerve crush in rodents; animal findings do not establish an effect in people.Animal study. Nayak et al., 2025 (Scientific Reports). PMID 41168281 ↗
- A review of natural molecules for brain health and resilience names the extract among the polyphenols discussed, summarising mechanistic rather than clinical evidence.Narrative review. Venetsanaki et al., 2026 (International Journal of Molecular Sciences). PMID 42196321 ↗
These are the studies our verdict leans on, chosen from the 177 we read for Pycnogenol (Skin). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.